Ugwu
Emilia U. Ugwu, Universal City, TX US
Patent application number | Description | Published |
---|---|---|
20100305010 | HIGH DENSITY PHOSPHATE BRINES AND METHODS FOR MAKING AND USING SAME - New heavy phosphate brines are disclosed, where the water soluble phosphate brines include two or more metal phosphate. Methods for making and using the heavy phosphate brines in drilling, completion, and fracturing operations are also disclosed. | 12-02-2010 |
Emilia U. Ugwu, Univ City, TX US
Patent application number | Description | Published |
---|---|---|
20100197968 | ALDEHYDE-AMINE FORMULATIONS AND METHOD FOR MAKING AND USING SAME - A novel method for producing amine-aldehyde sulfur scavenging compositions are disclosed, where the method comprises contacting an amine containing component and a aldehyde containing component in the presence of an alcohol at an amine to aldehyde ratio of between about 0.8 and 0.45 for a reaction time and at a reaction temperatures sufficient to produce an amine-aldehyde adduct product having a specific gravity between about 3% and 7% less than the specific gravity of a mixture of starting materials. | 08-05-2010 |
Sydney Ugwu, Gurnee, IL US
Patent application number | Description | Published |
---|---|---|
20090176852 | PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS - In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof. | 07-09-2009 |
20100331382 | PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS - In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof. | 12-30-2010 |
20140088166 | PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS - In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof. | 03-27-2014 |
Sydney Ugwu, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20100324126 | SYN3 COMPOSITIONS AND METHODS - Disclosed are aqueous and nonaqueous solution formulations containing agents that are useful for treating cancer. | 12-23-2010 |
Sydney O. Ugwu, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20150313926 | SYN3 COMPOSITIONS AND METHODS - Disclosed are aqueous and nonaqueous solution formulations containing agents that are useful for treating cancer. | 11-05-2015 |
Sydney O. Ugwu, Lisle, IL US
Patent application number | Description | Published |
---|---|---|
20160082005 | PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS - In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof. | 03-24-2016 |